Ask AI
ProCE Banner Activity

The Future of PBC Treatment Is Now

Clinical Thought

Learn how emerging data and therapies in development are transforming primary biliary cholangitis treatment goals and symptom management.

Released: November 24, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Target Audience

This activity is intended for physicians, including hepatologists and gastroenterologists, nurse practitioners, physician associates, nurses, pharmacists, and other healthcare professionals involved in the care of patients with PBC.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate emerging data regarding best practices for management of patients with PBC

  • Utilize emerging data to improve treatment plans for patients with PBC

  • Integrate expert guidance and patient insights into treatment plans for PBC

Disclosure

Primary Author

Gideon Hirschfield, MB BChir, FRCP, PhD: consultant/advisor/speaker: Advanz, Gilead, GSK, Kezar, Kowa, Intercept, Ipsen, Mirum, Pliant.